Neogen reports Q4 FY2026 revenue $225.3M, net loss $11.3M; core growth 4.3%

NEOGEN CORP

Q4 revenue $225.3M (flat YoY); core growth 4.3%; full-year revenue $870.4M, core growth 1.9%.
Net loss $11.3M ($0.05 EPS); adjusted net income $18.7M ($0.09 adjusted EPS).
Food Safety core growth 5.8% (highest since FY23); Animal Safety core growth 0.5% with sequential improvement.
Q4 adjusted EBITDA $45.4M (20.2% margin); operating cash flow $30.2M, free cash flow $26.2M.
Petrifilm manufacturing on track: first validated SKU by end of Aug 2026, sellable product in Nov 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.